A. M. Ibrado

K. Bhalla, A. M. Ibrado, G. Núñez, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells

K. Bhalla, A. M. Ibrado, J. Lutzky, 1993 .

1-β-d-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation

K. Bhalla, A. M. Ibrado, S. Ray, 1994, Cancer Chemotherapy and Pharmacology.

Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.

K. Bhalla, C. Kim, A. M. Ibrado, 1997, Cancer research.

Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors.

S. Arbuck, K. Bhalla, A. M. Ibrado, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.

K. Bhalla, A. M. Ibrado, Y. Huang, 1993, Experimental hematology.

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal and leukemic bone marrow progenitor cells.

K. Bhalla, A. M. Ibrado, J. Lutzky, 1992, Leukemia.

Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.

J. Reed, K. Bhalla, A. M. Ibrado, 1996, Leukemia.

Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells

John Calvin Reed, K. Bhalla, A. M. Ibrado, 1997, Leukemia.

Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.

K. Bhalla, A. M. Ibrado, A. Ibrado, 1997, Cancer research.

pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells.

K. Bhalla, A. M. Ibrado, S. Ray, 1995, Leukemia.

Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.

K. Bhalla, A. M. Ibrado, Linda Liu, 1996, Cancer research.

Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.

K. Bhalla, A. M. Ibrado, Y. Huang, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.